News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,238 stories indexed, page 28 of 138

🌍May 30Industrybicara.com

Featured signal

ASCO 2026 Poster Presentation: A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo in combination with pembrolizumab for first-line treatment of PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: FORTIFI-HN01

Publisher

Bicara Therapeutics

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Bicara TherapeuticsOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍May 30Industrybicara.com

ASCO 2026 Poster Presentation: The impact of depth of response on long-term clinical outcomes: Exploratory analyses from multiple expansion cohorts of a phase 1/1b study of ficerafusp alfa plus pembrolizumab in first-line recurrent/metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC)

Bicara TherapeuticsOriginal source

🌍May 30Industrybicara.com

ASCO 2026 Poster Presentation: Sustained depth and durability of response with TGF-β trapping in recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC): Long-term results from two expansion cohorts of a phase 1/1b study of ficerafusp alfa plus pembrolizumab

Bicara TherapeuticsOriginal source

🇸🇬May 30Researchscri.edu.sg

Clinical Research Coordinator Onboarding Programme (May 2026 Intake)

Singapore Clinical Research InstituteOriginal source

🌍May 30Industryfiercepharma.com

What Claims Data Misses: Finding Opportunity at the Point of Care

Fierce Pharma (Latest)Original source

🇺🇸May 30Industryyprime.com

How eCOA Supports Complex Obesity Clinical Trials and Long-Term Participant Engagement

YPrimeOriginal source

🇺🇸May 30CROadvarra.com

Do DSMBs Need AI Expertise?

Advarra (IRB)Original source

🇺🇸May 30Industrybiomarin.com

Kim Warner Builds Pathways for Early-Career Professionals Seeking Mission-Driven Opportunities

BioMarin PharmaceuticalOriginal source

🇨🇦May 30Researchnews.ubc.ca

UBC welcomes 45 scholars in first wave of Canada Impact+ Research Training Awards

University of British ColumbiaOriginal source

🌍May 30Regulatorybioworld.com

China launches long-awaited drug data protection rules

BioWorld NMPA RSSOriginal source

🌍May 29Industryapple.com

Detroit’s rising developers are supported by the Apple Developer Academy

Apple Health NewsroomOriginal source

🇫🇷May 29Regulatoryleem.org

3ème édition de la Journée Nationale de la Bioproduction de Biomédicaments : Le Leem se mobilise pour valoriser l’innovation française au service de la compétitivité

LEEM FranceOriginal source

🌍May 29Regulatoryifpma.org

79th World Health Assembly: Constituency statement on the follow-up to the Political Declaration on non-communicable diseases

IFPMA GlobalOriginal source

🇩🇪May 29Researchuni-heidelberg.de

Cooperation with Harvard: Cass R. Sunstein Visits Universität Heidelberg

Heidelberg UniversityOriginal source

🌍May 29Regulatorybioworld.com

BMS-Hengrui deal strikes panic in Washington

BioWorld Regulatory RSSOriginal source

🇨🇦May 29Researchnews.ubc.ca

UBC launches food prescription program with gift from RBC

University of British ColumbiaOriginal source

🇯🇵May 29Researchkyoto-u.ac.jp

Overcoming a Key Barrier to iPS Cell-Based T Cell Immunotherapy

Kyoto UniversityOriginal source

🇯🇵May 29Researchkyoto-u.ac.jp

Lost in an orange blur

Kyoto UniversityOriginal source

🇺🇸May 29Industrynews.abbvie.com

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

AbbVie NewsOriginal source

🇺🇸May 29Industrybristolmyers2016ir.q4web.com

Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma

Bristol-Myers Squibb NewsOriginal source

🌍May 29Industryaptose.com

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

Aptose BiosciencesOriginal source

🌍May 29Industryaspenpharma.com

Meet our people: Nicolas Lachèvre, IT OPS work‑study student at Aspen NDB

Aspen PharmacareOriginal source

🇺🇸May 29Researchaacr.org

AACR D3: The ‘Global One-stop Conference’ for Drug Discovery and Development

AACROriginal source

🇺🇸May 29CROir.labcorp.com

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Drug DevelopmentOriginal source

🌍May 29Regulatoryravimiamet.ee

The Estonian medicinal products market in the first quarter 2026

SAM EstoniaOriginal source

🇺🇸May 29Industrymerck.com

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Merck & Co. (MSD) NewsOriginal source

🇬🇧May 29Researchmed.cam.ac.uk

Cambridge researchers map the human endocrine system cell by cell

University of Cambridge - Clinical Medicine NewsOriginal source

🌍May 29Mediacentogene.com

Reproductive Carrier Screening Portoflio Update

CentogeneOriginal source

🌍May 29Industrybioinformaticsonline.com

Update for ComBioX

BioInformatics OnlineOriginal source

🇩🇪May 29pharma_equipmentsyntegon.com

Annex 1 compliance as a competitive advantage

Syntegon (Bosch Packaging)Original source

🇪🇸May 29Regulatoryaemps.gob.es

La AEMPS publica su Código de Conducta

AEMPS (Spain)Original source

🇬🇧May 29Researched.ac.uk

Nominations open for 2026 Principal’s Medals

University of EdinburghOriginal source

🇮🇹May 29Researchhumanitas.it

Anche Humanitas alla MILANO HEALTH WEEK 2026: dal 4 al 6 giugno, in Piazza Gae Aulenti

Humanitas Research HospitalOriginal source

🌍May 29Industryaspenpharma.com

Aspen Announces Successful Completion of Aspen APAC Divestment

Aspen PharmacareOriginal source

🇮🇹May 29Researchhumanitas.it

Dieci anni di Urologia in Humanitas: un evento scientifico dedicato

Humanitas Research HospitalOriginal source

🇯🇵May 29Industrynewsroom.astellas.com

Notice Regarding the Resignation of an Outside Director and Partial Withdrawal of Matters to be Resolved at the 21st Term Annual Shareholders Meeting

Astellas PharmaOriginal source

🇫🇷May 29Researchchu-lille.fr

Participez à la Marche du Mont des Cats, le 07 juin

CHU LilleOriginal source

🌍May 29Industryavacta.com

Posting of Annual Report and Notice of AGM

Avacta GroupOriginal source

🇺🇸May 29Mediabio-itworld.com

Immunai, AstraZeneca Expand Partnership, Rancho Biosciences Releases Multi-omics Datasets, Dotmatics AI Co-Scientist

Bio-IT WorldOriginal source

🇯🇵May 29Regulatorypmda.go.jp

[SHINSA]English translation of review report: Coseal

PMDA JapanOriginal source

🇯🇵May 29Industrynewsroom.astellas.com

Astellas’ View on ISS Voting Recommendations

Astellas PharmaOriginal source

🌍May 29Regulatorypharmac.govt.nz

Agenda for July 2026 Rare Disorders Advisory Committee meeting

Pharmac New ZealandOriginal source

🇯🇵May 29Industrysumitomo-pharma.com

Posted Notice of Convocation of the 206th Annual Shareholders' Meeting

Sumitomo PharmaOriginal source

🇯🇵May 29Industryotsuka.co.jp

Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Otsuka Holdings RSSOriginal source

🇬🇧May 29Researchnature.com

Environmental and developmental factors shape anti-AAV immunity in pigs

Nature Gene TherapyOriginal source

🇺🇸May 29Researchnewsroom.clevelandclinic.org

Cleveland Clinic Appoints Miguel Regueiro, M.D., Executive Vice President and Enterprise Chief of Staff

Cleveland Clinic Main CampusOriginal source

🇪🇸May 29Researchcnic.es

José Javier Fuster recibe el Premio ESCI 2026 por su excelencia en investigación clínica

CNIC Spain CardiovascularOriginal source

🇪🇸May 29Researchcnic.es

Jonatan R. Ruiz: "Son pequeños cambios sostenidos los que pueden generar grandes beneficios a largo plazo"

CNIC Spain CardiovascularOriginal source

🇺🇸May 29CROadvarra.com

What Protocol Amendments Reveal About Trial Design

Advarra (IRB)Original source

🌍May 29Industryir.allogene.com

Allogene Therapeutics Announces Planned CEO Succession

Allogene TherapeuticsOriginal source

🇺🇸May 29CDMOinvestors.emergentbiosolutions.com

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

Emergent BioSolutionsOriginal source

🇨🇭May 29CROpsi-cro.com

Radiopharmaceutical Imaging in Pivotal Trials: Aligning Sites, CROs, and Sponsors for Operational Success Session

PSI CROOriginal source

🇨🇭May 29CROpsi-cro.com

Radiopharmaceutical Imaging in Pivotal Trials: Aligning Sites, CROs, and Sponsors for Operational Success

PSI CROOriginal source

🇺🇸May 29Mediabio-itworld.com

Insilico Medicine, Human Longevity Partner for Longevity Foundation Model

Bio-IT WorldOriginal source

🇺🇸May 29Industrybiomarin.com

Why Do I Pheel This Way? New Video Podcast Series Sheds Light on Navigating Adolescence with Phenylketonuria

BioMarin PharmaceuticalOriginal source

🇺🇸May 29Industryinvestor.lilly.com

Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care

Eli Lilly NewsOriginal source

🌍May 29Mediaskpharmteco.com

Accelerating AAV5 Purification Development with High-Throughput Screening

SkpharmtecoOriginal source

🌍May 29Mediaskpharmteco.com

Lentiviral Vector Purification for In Vivo Applications

SkpharmtecoOriginal source

🌍May 29Researchopenclinica.com

Why Your Study Workflow Is Broken (And It’s Not Your Team)

OpenClinicaOriginal source

🇬🇧May 29Researched.ac.uk

Tales of identity and uprising win book awards

University of EdinburghOriginal source

Pharmaceutical industry news

Search-friendly hub pages

Regulatory Updates

Clinical Trial Watch

Drug Pipeline

Every signal, indexed and searchable

Latest indexed stories

ASCO 2026 Poster Presentation: A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo in combination with pembrolizumab for first-line treatment of PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: FORTIFI-HN01

ASCO 2026 Poster Presentation: Sustained depth and durability of response with TGF-β trapping in recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC): Long-term results from two expansion cohorts of a phase 1/1b study of ficerafusp alfa plus pembrolizumab

Clinical Research Coordinator Onboarding Programme (May 2026 Intake)

What Claims Data Misses: Finding Opportunity at the Point of Care

How eCOA Supports Complex Obesity Clinical Trials and Long-Term Participant Engagement

Do DSMBs Need AI Expertise?

Kim Warner Builds Pathways for Early-Career Professionals Seeking Mission-Driven Opportunities

UBC welcomes 45 scholars in first wave of Canada Impact+ Research Training Awards

China launches long-awaited drug data protection rules

Detroit’s rising developers are supported by the Apple Developer Academy

3ème édition de la Journée Nationale de la Bioproduction de Biomédicaments : Le Leem se mobilise pour valoriser l’innovation française au service de la compétitivité

79th World Health Assembly: Constituency statement on the follow-up to the Political Declaration on non-communicable diseases

Cooperation with Harvard: Cass R. Sunstein Visits Universität Heidelberg

BMS-Hengrui deal strikes panic in Washington

UBC launches food prescription program with gift from RBC

Overcoming a Key Barrier to iPS Cell-Based T Cell Immunotherapy

Lost in an orange blur

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

Meet our people: Nicolas Lachèvre, IT OPS work‑study student at Aspen NDB

AACR D3: The ‘Global One-stop Conference’ for Drug Discovery and Development

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

The Estonian medicinal products market in the first quarter 2026

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Cambridge researchers map the human endocrine system cell by cell

Reproductive Carrier Screening Portoflio Update

Update for ComBioX

Annex 1 compliance as a competitive advantage

La AEMPS publica su Código de Conducta

Nominations open for 2026 Principal’s Medals

Anche Humanitas alla MILANO HEALTH WEEK 2026: dal 4 al 6 giugno, in Piazza Gae Aulenti

Aspen Announces Successful Completion of Aspen APAC Divestment

Dieci anni di Urologia in Humanitas: un evento scientifico dedicato

Notice Regarding the Resignation of an Outside Director and Partial Withdrawal of Matters to be Resolved at the 21st Term Annual Shareholders Meeting

Participez à la Marche du Mont des Cats, le 07 juin

Posting of Annual Report and Notice of AGM

Immunai, AstraZeneca Expand Partnership, Rancho Biosciences Releases Multi-omics Datasets, Dotmatics AI Co-Scientist

[SHINSA]English translation of review report: Coseal

Astellas’ View on ISS Voting Recommendations

Agenda for July 2026 Rare Disorders Advisory Committee meeting

Posted Notice of Convocation of the 206th Annual Shareholders' Meeting

Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Environmental and developmental factors shape anti-AAV immunity in pigs

Cleveland Clinic Appoints Miguel Regueiro, M.D., Executive Vice President and Enterprise Chief of Staff

José Javier Fuster recibe el Premio ESCI 2026 por su excelencia en investigación clínica

Jonatan R. Ruiz: &quot;Son pequeños cambios sostenidos los que pueden generar grandes beneficios a largo plazo&quot;

What Protocol Amendments Reveal About Trial Design

Allogene Therapeutics Announces Planned CEO Succession

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

Radiopharmaceutical Imaging in Pivotal Trials: Aligning Sites, CROs, and Sponsors for Operational Success Session

Radiopharmaceutical Imaging in Pivotal Trials: Aligning Sites, CROs, and Sponsors for Operational Success

Insilico Medicine, Human Longevity Partner for Longevity Foundation Model

Why Do I Pheel This Way? New Video Podcast Series Sheds Light on Navigating Adolescence with Phenylketonuria

Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care

Accelerating AAV5 Purification Development with High-Throughput Screening

Lentiviral Vector Purification for In Vivo Applications

Why Your Study Workflow Is Broken (And It’s Not Your Team)

Tales of identity and uprising win book awards

Jonatan R. Ruiz: "Son pequeños cambios sostenidos los que pueden generar grandes beneficios a largo plazo"